Latest stories on TEM
Tempus AI, Inc. (TEM) Analyst/Investor Day Transcript
Seeking Alpha53 · neutralanalyst
H.C. Wainwright Maintains Buy Rating on Tempus AI (TEM) Following Strong Revenue Growth
Yahoo Top61 · neutralanalyst
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH | TEM Stock News
StockTitan67 · bullishproduct/pr
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development | TEM Stock News
StockTitan67 · bullishproduct/pr
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results | TEM Stock News
StockTitan61 · neutralproduct/pr
Tempus AI, Inc. (TEM) Analyst/Investor Day - Slideshow
Seeking Alpha50 · neutralproduct/pr
"AI that predicts clinical outcomes?" Tempus AI in focus after ASCO data reveal
Seeking Alpha67 · bullishproduct/pr
Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio | TEM Stock News
StockTitan77 · bullishproduct/pr
Tempus AI (TEM) Launches ArteraAI Prostate Test, The First Externally Developed Digital Pathology Algorithm
Yahoo Top61 · neutralproduct/pr
Tempus AI, Inc. (TEM) and Bristol Myers Announce a Strategic Partnership
Yahoo Finance61 · neutralproduct/pr
Tempus AI Stockholders Confirm Board, Auditor and Say-on-Pay
TipRanks50 · neutralgeneral
Tempus AI: Taking Advantage Of Investor Myopia
Seeking Alpha67 · bullishproduct/pr
How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here
Yahoo Top61 · neutralgeneral
Here’s Why Aristotle Core Equity Fund Bets on Tempus AI (TEM), a Healthcare Technology Company
Yahoo Top61 · neutralanalyst
Is Tempus AI (TEM) The Best AI Healthcare Stock to Buy?
Yahoo Top61 · neutralgeneral